tm
Seeing Is Believing
tm
Seeing Is Believing
VRDN is currently covered by 12 analysts with an average price target of $30.92. This is a potential upside of $17.89 (137.3%) from yesterday's end of day stock price of $13.03.
Viridian Therapeutics's activity chart (see below) currently has 7 price targets and 55 ratings on display. The stock rating distribution of VRDN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 12.77% with an average time for these price targets to be met of 121.54 days.
Highest price target for VRDN is $51, Lowest price target is $29, average price target is $30.92.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 29-Feb-2024. First documented stock forecast 20-Jan-2021.
Currently out of the existing stock ratings of VRDN, 50 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
37
$23.97 (183.96%)
37
1 months 28 days ago
1/8 (12.5%)
$18.29 (97.76%)
40
Buy
30
$16.97 (130.24%)
30
1 months 29 days ago
0/6 (0%)
$9.83 (48.74%)
Buy
40
$26.97 (206.98%)
39
1 months 29 days ago
0/7 (0%)
$19.83 (98.31%)
Buy
36
$22.97 (176.29%)
35
4 months 7 days ago
0/4 (0%)
$13.77 (61.94%)
Buy
35
$21.97 (168.61%)
35
4 months 12 days ago
0/6 (0%)
$15.66 (80.97%)
What is VRDN (Viridian Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VRDN (Viridian Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VRDN (Viridian Therapeutics)?
Which analyst is the currently most bullish on VRDN (Viridian Therapeutics)?
Which analyst is the currently most reserved on VRDN (Viridian Therapeutics)?
